Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →You can get GLP-1 shots online only with a prescription from a licensed clinician. A legitimate telehealth clinic reviews your health history, confirms eligibility, prescribes when appropriate, and sends the medication through a licensed pharmacy. Options may include brand-name GLP-1s or compounded semaglutide or tirzepatide when clinically appropriate.
Can you get GLP-1 shots online?
Yes. GLP-1 shots can be prescribed online when a licensed clinician decides they are appropriate after a medical review. A real online visit should include more than a checkout page: it should confirm identity, screen for contraindications, review medications, and give you a way to ask follow-up questions.
What an online GLP-1 visit usually includes
- A health questionnaire covering height, weight, BMI, weight history, current medications, allergies, pregnancy status, and health conditions.
- A clinician review for obesity, overweight with weight-related conditions, type 2 diabetes, prediabetes, hypertension, high cholesterol, sleep apnea, PCOS, cardiovascular disease, and other risk factors.
- A safety screen for pancreatitis, gallbladder disease, severe stomach-emptying problems, kidney issues, and personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, which are listed warnings or contraindications on GLP-1 and GIP/GLP-1 labels 1, 2, 3.
- A prescription only if the clinician determines treatment is appropriate.
Why a prescription is required
GLP-1 receptor agonists affect appetite regulation, insulin secretion, glucagon suppression, and delayed gastric emptying. These effects can be helpful for weight and blood sugar in the right patient, but they also create real risks, including gastrointestinal side effects and rare serious events such as pancreatitis or gallbladder problems 1, 2, 4.
What online clinics can and cannot promise
A clinic can promise a medical review, transparent pricing, and licensed pharmacy fulfillment. It cannot promise that you will qualify, that a specific medicine is right for you, or that you will lose a certain amount of weight. Individual results vary, even in large trials 5, 6.
What GLP-1 shots are used for weight loss?
The main injectable medicines used in weight care are semaglutide, tirzepatide, and liraglutide. Semaglutide 2.4 mg once weekly was studied in the STEP 1 trial as the active ingredient in a chronic weight-management program, but compounded formulations do not have FDA-evaluated outcomes data 5. Side effects and contraindications must be weighed with any expected benefit 1.
Semaglutide: Wegovy, Ozempic, and compounded semaglutide
Semaglutide is a glucagon-like peptide-1, or GLP-1, receptor agonist. Wegovy is FDA-approved for chronic weight management in eligible adults and certain adolescents, while Ozempic is FDA-approved for type 2 diabetes and specific cardiovascular and kidney risk-reduction uses in labeled populations 1, 7. At Chia, we offer compounded semaglutide injection through licensed-provider review and 503A pharmacy fulfillment when clinically appropriate.
Tirzepatide: Zepbound, Mounjaro, and compounded tirzepatide
Tirzepatide is a GIP/GLP-1 receptor agonist, meaning it activates receptors for glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. Zepbound is FDA-approved for chronic weight management in eligible adults and for obstructive sleep apnea in adults with obesity, while Mounjaro is FDA-approved for type 2 diabetes 2, 8. At Chia, compounded tirzepatide is available as injection or tablets after clinician review.
Liraglutide: Saxenda and Victoza
Liraglutide is an older GLP-1 receptor agonist. Saxenda is FDA-approved for chronic weight management in eligible patients and is injected once daily, while Victoza is FDA-approved for type 2 diabetes and certain cardiovascular risk-reduction uses 3, 9. Daily dosing can be a trade-off for some patients, and liraglutide shares common GLP-1 risks such as nausea, vomiting, diarrhea, constipation, pancreatitis warnings, and gallbladder concerns 3.
What about orforglipron?
Orforglipron is an oral small-molecule GLP-1 receptor agonist being studied for obesity and type 2 diabetes. In a phase 2 obesity trial, daily orforglipron was linked with weight loss over 36 weeks, but gastrointestinal side effects were common, and it is not an FDA-approved weight-loss medicine at this time 10. Chia does not offer orforglipron.
How do GLP-1 injections help with weight loss?
GLP-1 injections work mainly by changing appetite and fullness signals. In plain English, they help the brain and gut communicate that you are full sooner and for longer, while also affecting blood sugar hormones 4.
- Appetite signaling: GLP-1 activity in the brain can reduce hunger and food reward, which may lower calorie intake 4.
- Slower stomach emptying: GLP-1 medicines can delay gastric emptying, which can increase fullness but may also worsen nausea, reflux, or bloating in some people 1, 4.
- Insulin and glucagon: GLP-1 receptor agonists can increase glucose-dependent insulin secretion and reduce glucagon when blood sugar is high, which is why several are used in type 2 diabetes 7, 9.
- Lifestyle pairing: In major weight-loss trials, medication was paired with nutrition and activity support, so medication alone should not be viewed as the whole plan 5, 6.
The same mechanisms that help with fullness can also cause side effects. Nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder events, and rare pancreatitis are listed in GLP-1 labeling and should be reviewed before treatment 1, 2, 3.
Who may be eligible for GLP-1 shots online?
Eligibility depends on BMI, health history, medications, and clinician judgment. BMI criteria on FDA weight-management labels commonly include obesity, or overweight with at least one weight-related condition, but the right decision is personal 1, 2, 3.
Common BMI and weight-related health criteria
FDA-approved chronic weight-management labels for semaglutide, tirzepatide, and liraglutide include adults with obesity, or adults with overweight plus at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes 1, 2, 3. Some labels and trials also include conditions such as obstructive sleep apnea or cardiovascular disease in specific populations 1, 2, 11.
Who may not be a good candidate
A clinician may avoid GLP-1 or GIP/GLP-1 treatment in patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, certain severe gastrointestinal conditions, pregnancy, or past serious reactions to the medication 1, 2, 3. They may also ask for labs or in-person care if symptoms or history suggest higher risk.
How much do GLP-1 shots cost online?
Online GLP-1 costs vary a lot because the total may include a visit fee, membership fee, medication cost, shipping, labs, and refills. Without insurance, brand-name GLP-1 list prices can be much higher than many compounded cash-pay programs, but your real cost depends on coverage, coupon rules, and the pharmacy.
Brand-name costs, savings cards, and $25 pricing
Some people see low copays for brand-name Wegovy, Zepbound, Ozempic, or Mounjaro because of insurance coverage or manufacturer savings programs. Those prices are not available to everyone and can depend on diagnosis, commercial insurance status, plan rules, supply, and prior authorization.
Cash-pay and compounded GLP-1 pricing
Cash-pay compounded programs may be easier to compare because the patient often pays directly. At Chia, compounded semaglutide injection plans currently start at $249/month, and compounded tirzepatide injection plans currently start at $299/month. Tirzepatide tablets are also available through Chia, with plans currently starting at $249/month; see the tirzepatide page for current pricing.
What to compare before you pay
- Clinician visit or membership fee
- Medication price
- Whether shipping is included
- Refill timing and cancellation policy
- Whether the dispensing pharmacy is state-licensed
- Whether follow-up and side-effect support are included
3-min quiz
Considering GLP-1 treatment?
Chia offers clinician-reviewed compounded semaglutide injection and compounded tirzepatide injection or tablets, with home delivery from state-licensed 503A pharmacies when prescribed. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
How do brand-name and compounded GLP-1 shots compare?
Brand-name and compounded GLP-1s are different paths. Brand-name medications have FDA-approved labeling and FDA-reviewed clinical data for their approved uses; compounded medications are prepared for an individual prescription by a licensed compounding pharmacy and are not FDA-approved 12.
| Feature | Brand-name GLP-1 shots | Compounded GLP-1 shots |
|---|---|---|
| Examples | Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda | Compounded semaglutide via 503A pharmacy; compounded tirzepatide via 503A pharmacy |
| FDA status | FDA-approved for specific labeled indications | Not FDA-approved; prescribed when a licensed clinician determines it is appropriate |
| Evidence | Clinical trials and labeling are tied to the specific FDA-approved product and use 1, 2, 5, 6 | Outcomes are not established for compounded formulations; clinicians may rely on the active ingredient evidence while considering formulation-specific limits |
| Cost path | Often insurance, prior authorization, manufacturer savings, or cash-pay list price | Often cash-pay program pricing |
| Pharmacy path | Commercial manufacturer supply chain | State-licensed 503A compounding pharmacy for an individual prescription |
| What to verify | Indication, insurance coverage, pharmacy availability, and side-effect plan | Licensed clinician review, pharmacy licensing, clear pricing, and follow-up access |
The FDA has warned patients not to use GLP-1 products sold without a prescription or from unverified sources, and has also reported dosing errors and adverse events with compounded semaglutide products 12, 13. The key safety divide is licensed care and licensed pharmacy dispensing versus no-prescription “research” or gray-market sellers.
Getting GLP-1 shots online through Chia
At Chia, GLP-1 treatment starts with a 100% online health questionnaire and licensed-provider review. If prescribed, medication is compounded in the U.S. by a state-licensed 503A pharmacy and shipped to your door; dosing is provider-guided and adjusted over time.
What Chia offers for GLP-1 treatment
| Chia option | Forms | Current starting price | Notes |
|---|---|---|---|
| Semaglutide | Injection | From $249/month | Microdosing plans available when clinically appropriate; see semaglutide |
| Tirzepatide | Injection and tablets | Injection from $299/month; tablets from $249/month | Microdosing plans available when clinically appropriate; see tirzepatide |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/month | A multi-treatment protocol option; see Weight + Energy |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | From $329/month | A multi-treatment protocol option; see Weight + Muscle |
Microdosing at Chia means the dose plan is guided by a provider and adjusted over time when clinically appropriate. It is not a do-it-yourself protocol. Your provider reviews side effects, progress, and health changes through the patient portal.
How can you tell if an online GLP-1 clinic is legitimate?
A legitimate clinic uses licensed clinicians, licensed pharmacies, clear pricing, and real follow-up. No prescription guarantee is a good sign, not a bad one, because GLP-1 treatment is not right for everyone.
- Licensed U.S. clinician review before any prescription.
- State-licensed pharmacy dispensing, not a no-prescription research chemical source.
- Clear medication, visit, membership, refill, and shipping fees.
- No claims that compounded products are the same as, equivalent to, or generic versions of Wegovy, Ozempic, Zepbound, or Mounjaro.
- A plan for nausea, vomiting, diarrhea, constipation, dehydration, gallbladder symptoms, and urgent warning signs.
- Secure messaging or follow-up visits after the prescription, not a one-time transaction.
What side effects and safety issues should you know about?
The most common GLP-1 side effects are gastrointestinal. Nausea and vomiting are common enough that labels and trials pay close attention to them, and they can lead to dehydration or kidney stress if severe 1, 2, 5, 6.
Common side effects
- Nausea, vomiting, diarrhea, constipation, abdominal pain, burping, reflux, and decreased appetite 1, 2, 3.
- Low blood sugar risk can rise when GLP-1 or GIP/GLP-1 medications are used with insulin or sulfonylureas 7, 8.
- Delayed gastric emptying may affect how some oral medicines are absorbed and may matter before procedures requiring anesthesia 1, 2.
Serious warnings to discuss
Talk with a clinician about pancreatitis symptoms, gallbladder disease, kidney problems from dehydration, severe stomach symptoms, mood changes listed on some weight-management labels, and the boxed warning about thyroid C-cell tumors seen in rodents 1, 2, 3. Seek urgent care for severe or persistent abdominal pain, repeated vomiting, signs of dehydration, allergic reaction, or chest pain.
FAQ
There is no single cheapest option for everyone. Brand-name costs depend on insurance, coupons, and pharmacy access. Cash-pay compounded programs may have clearer monthly pricing. At Chia, compounded semaglutide injection plans currently start at $249/month, and compounded tirzepatide injection plans currently start at $299/month.
Yes. GLP-1 shots require a prescription from a licensed clinician. A legitimate online clinic reviews your health history and prescribes only when appropriate.
Some people pay low copays for brand-name semaglutide because of insurance coverage or manufacturer savings programs. Those programs have eligibility rules and are not available to everyone.
Pharmacy prices can change by medication, dose form, insurance plan, coupon, and location. If you are comparing costs, ask for the medication price, visit fee, refill fee, shipping cost, and any membership fee separately.
Online clinicians can prescribe medications only when medically appropriate. Ozempic has FDA-approved uses for type 2 diabetes and certain cardiovascular and kidney risk-reduction uses in labeled populations; using it outside its approved indication may be off-label.
No. Compounded GLP-1 shots are not the same as, equivalent to, or generic versions of Wegovy or Zepbound. Brand-name products have FDA-approved labeling and FDA-reviewed outcomes for their approved uses. Compounded drugs are not FDA-approved, and outcomes are not established for compounded formulations.
Yes, when prescribed through a legitimate telehealth clinic and dispensed by a licensed pharmacy, GLP-1 medication may be shipped to your home. At Chia, prescribed compounded medications are shipped from state-licensed 503A pharmacies.
Yes. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health. A licensed clinician still reviews eligibility, and a prescription is never guaranteed.
3-min quiz
Start with a clinician-reviewed GLP-1 evaluation
If you want to understand whether semaglutide or tirzepatide may fit your goals, you can start Chia’s online visit. A licensed provider reviews your health history and prescribes only when clinically appropriate; medications are compounded by state-licensed 503A pharmacies and shipped to your door when prescribed.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information, 2024.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information, 2025.
- 3.U.S. Food and Drug Administration. Saxenda (liraglutide) injection prescribing information, 2023.
- 4.Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism, 2018.
- 5.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021.
- 6.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022.
- 7.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information, 2025.
- 8.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information, 2025.
- 9.U.S. Food and Drug Administration. Victoza (liraglutide) injection prescribing information, 2023.
- 10.Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, et al. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. New England Journal of Medicine, 2023.
- 11.Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 2023.
- 12.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, 2025.
- 13.U.S. Food and Drug Administration. FDA Alerts Health Care Providers, Compounders and Patients of Dosing Errors Associated with Compounded Injectable Semaglutide Products, 2024.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
